Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Onyx Healthcare's FCF Margin % or its related term are showing as below:
ROCO:6569'
s FCF Margin % Range Over the Past 10 Years
Min: -23.2 Med: 10.91 Max: 24.79
Current: -3.46
During the past 13 years, the highest FCF Margin % of Onyx Healthcare was 24.79%. The lowest was -23.20%. And the median was 10.91%.
ROCO:6569's FCF Margin % is ranked worse than 68.51% of 670
companies
in the Healthcare Providers & Services industry
Industry Median: 3.13
vs ROCO:6569: -3.46
The historical data trend for Onyx Healthcare's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6569 vs VEEV, BTSG, HQY: FCF Margin % Comparison
For the Health Information Services subindustry, Onyx Healthcare's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Onyx Healthcare FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Onyx Healthcare's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Onyx Healthcare's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Onyx Healthcare (ROCO:6569) has a FCF Margin % of -12.04% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Onyx Healthcare and its competitors. According to the industry distribution chart, Onyx Healthcare ranks #459 out of 670 companies in the Healthcare Providers & Services industry, placing it in the top 68.5%.
Is Onyx Healthcare's FCF Margin % too high?
Onyx Healthcare's current FCF Margin % is -12.04%. Based on the distribution chart, Onyx Healthcare ranks #459 out of 670 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Onyx Healthcare has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Onyx Healthcare's FCF Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Onyx Healthcare ranks #459 out of 670 companies for FCF Margin %. This places Onyx Healthcare in the lower half of its industry. The industry median FCF Margin % is 3.13. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.13, based on 670 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Onyx Healthcare and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Onyx Healthcare's current FCF Margin % is -12.04%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Onyx Healthcare (ROCO:6569) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$136.25, compared to a current price of NT$91.80 — trading 32.6% below its estimated fair value. The current FCF Margin % is -12.04%. Onyx Healthcare's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Onyx Healthcare (ROCO:6569), the current FCF Margin % is -12.04% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Onyx Healthcare (ROCO:6569) Overvalued in 2026?
Based on GuruFocus' analysis, Onyx Healthcare stock appears to be undervalued.
The current stock price of NT$91.80 is trading 32.6% below its estimated GF Value™ of NT$136.25.
GuruFocus considers Onyx Healthcare to be Significantly Undervalued.
Key valuation signals for ROCO:6569:
FCF Margin %: -12.04%
GF Value™: NT$136.25 vs. price of NT$91.80 (32.6% below fair value)
No single metric tells the full story. See the ROCO:6569 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Onyx Healthcare Inc is engaged in designing, manufacturing, and trading of medical computers and peripherals. The company provides medical products such as AI Ready Medical PC and Tablet, Medical PC & Monitor for Digital OR (ACCEL), Telemedicine, Medical Cart Computer(Venus), Medical Power Panel PC (Mini Venus), Power Bank (UPower), Battery Management System (ORION), Mobile Medical Tablet (MD), Professional Medical All in One PC (ZEUS), etc. It operates in Taiwan, the United States, Europe, and Other countries and generates maximum revenue from Taiwan.
75GF Score
Get the complete analysis for ROCO:6569
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6569 has been successfully added to your 
